Picture of Lexicon Pharmaceuticals logo

LXRX — Lexicon Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Lexicon Pharmaceuticals Inc reports results for the quarter - Earnings Summary

* Lexicon Pharmaceuticals Inc  LXRX.OQ  reported a quarterly
adjusted loss of 18 cents​​ per share for the quarter , higher
than the same quarter last year, when the company reported EPS
of -21 cents.  The mean expectation of six analysts for the
quarter was for a loss of 16 cents per share. Wall Street
expected results to range from -18 cents to -15 cents per share.
    * Revenue rose 980.2% to $1.75 million from a year ago;
analysts
expected $2.93 million. 
    * Lexicon Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 18 cents​.
    * The company reported a quarterly loss of $64.81 million.
    * Lexicon Pharmaceuticals Inc shares had fallen by 19.1%
this
quarter and lost 17.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Lexicon
Pharmaceuticals Inc is 5.00 
This summary was machine generated from LSEG data November 12 at
11:26 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.16          -0.18          Missed
 Jun. 30 2024      -0.19          -0.17          Beat
 Mar. 31 2024      -0.20          -0.20          Met
 Dec. 31 2023      -0.22          -0.20          Beat

Recent news on Lexicon Pharmaceuticals

See all news